Dallas, TX, March 27, 2016 --(PR.com
)-- Wound care management is a growing field that has been witnessing a number of technological advancements lately. There are various products available in the market which have made treatment of wounds easier. The companies operating in the global advanced wound care market are focusing on incorporating advanced and innovative features in their products to differentiate them from other products available in the market. Companies operating in this market are focusing on acquisitions to strengthen their product portfolio and enhance their market position.
The global advanced wound care market is expected to reach $17.8 billion by 2022 from $10.8 billion in 2015, at a CAGR of 7.3% from 2016 to 2022. Factors, such as introduction of new and advanced wound care products along with tremendous support in the form of funds and grants from various government bodies across the globe are fueling the growth of this market. Technological advancements in wound care management, prevalence of obesity-related diseases such as diabetes, and increasing aging population are also contributing towards the growth of the global advanced wound care market. However, factors such as high costs of active wound care treatment and products may restrain the growth of this market.
The global advanced wound care market is segmented on the basis of product type, application, and end user. Furthermore, the market is classified on the basis of geography into North America, Europe, Asia-Pacific, South America and Rest of the World (RoW). RoW majorly comprises the Middle East, and Africa. By product type, the global advanced wound care market is divided into dressings, therapy devices, and active wound care. The dressing segment accounted for the largest share of 46.8% in the global advanced wound care market in 2015.
On the basis of application, the market is segmented into surgical wounds, ulcers, and others. Among applications, the surgical wound segment accounted for the largest share of 42.5% in the global advanced wound care market in 2015.
By end user, the market is further classified into in-patient facility and out-patient facility. The in-patient facility segment accounted for the largest market share of 75.4% in 2015.
Acelity L.P., Inc. (U.S.) held the largest market share in the global advanced wound care market in 2015 and accounted for a market share of about 25.7%. Diversified product portfolio within advanced wound care and consistent alliances to obtain inorganic growth enabled Acelity L.P., Inc. to generate maximum revenues from the market. Smith & Nephew plc (U.K.) & Mölnlycke Health Care (Sweden) followed Acelity L.P., Inc. Other major players operating in this market include Medline Industries, Inc. (U.S.), Organogenesis Inc. (U.S.), Integra LifeSciences Corporation. (U.S.), MiMedx Group, Inc. (U.S.), and others.
For free sample of the report